Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2375 of 2873 entries
View as:

Combination Chemotherapy in Treating Patients With Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002835 Org: User:
Start: 10/30/95 End: 02/04/04 Due: 02/04/05

Cancer Genetics CD-ROM for Hispanics

Phase: N/A Priority: Normal
NCT ID: NCT00525980 Org: User:
Start: 02/28/07 End: 03/31/13 Due: 03/31/14

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01101412 Org: User:
Start: - End: - Due: -

Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04013542 Org: User:
Start: 09/13/19 End: 12/31/27 Due: 12/31/28

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

Phase: N/A Priority: Normal
NCT ID: NCT06284486 Org: User:
Start: 09/23/24 End: 12/30/28 Due: 12/30/29

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04565665 Org: User:
Start: 07/29/20 End: 04/30/26 Due: 04/30/27

Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03524170 Org: User:
Start: 04/30/18 End: 02/10/22 Due: 02/10/23

Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03224000 Org: User:
Start: 01/17/18 End: 12/30/25 Due: 12/30/26

Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00739063 Org: User:
Start: 07/31/08 End: 11/30/10 Due: 11/30/11

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04521946 Org: User:
Start: 01/14/21 End: 12/20/22 Due: 12/20/23

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01596140 Org: User:
Start: 12/18/12 End: 06/01/20 Due: 06/01/21

Psychosocial Impact of Cancer-Related Female Infertility

Phase: N/A Priority: Normal
NCT ID: NCT00386217 Org: User:
Start: 12/31/04 End: 11/30/08 Due: 11/30/09

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT05501054 Org: User:
Start: 02/09/23 End: 11/01/26 Due: 11/01/27

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04678427 Org: User:
Start: 11/13/20 End: 12/31/25 Due: 12/31/26

An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study

Phase: N/A Priority: Normal
NCT ID: NCT05056805 Org: User:
Start: 03/04/21 End: 09/08/22 Due: 09/08/23

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Phase: N/A Priority: Normal
NCT ID: NCT01365169 Org: User:
Start: 05/25/11 End: 06/30/27 Due: 06/30/28

Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05046067 Org: User:
Start: 09/16/20 End: 07/19/24 Due: 07/19/25

MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial

Phase: N/A Priority: Normal
NCT ID: NCT04580836 Org: User:
Start: 08/19/20 End: 11/17/21 Due: 11/17/22

CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization

Phase: N/A Priority: Normal
NCT ID: NCT03990623 Org: User:
Start: 07/21/18 End: 04/30/24 Due: 04/30/25

Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00967044 Org: User:
Start: 11/30/09 End: 03/31/14 Due: 03/31/15

An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05904899 Org: User:
Start: 08/01/23 End: 12/31/26 Due: 12/31/27

Stage I/II Nasal NK Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01321008 Org: User:
Start: 05/31/11 End: 05/31/13 Due: 05/31/14

Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care

Phase: N/A Priority: Normal
NCT ID: NCT06850402 Org: User:
Start: 06/01/25 End: 09/01/28 Due: 09/01/29

Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03844620 Org: User:
Start: 01/29/19 End: 08/31/26 Due: 08/31/27

Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01794702 Org: User:
Start: 02/20/13 End: 01/11/18 Due: 01/11/19